News

Led by an investigator at the University of Minnesota, the study showed 75% of patients treated with Aldara Cream three times per week, and nearly 60% treated two

Multiferon is now approved in Chile for the second-line treatment of any and all diseases in which recombinant interferon therapy failed, possibly due to the formation of neutralizing

Saber-Bupivacaine is based on Durect’s patented Saber delivery technology and is intended to be administered around the surgical site after surgery to provide three days or more of

Under the agreement, Cerner will provide its Millennium software suite as part of a project to develop a fully operational electronic medical record (EMR) system, with the first

Based on the FDA’s assessment of currently data and the availability of other treatment options in the US that do prolong life, AstraZeneca said that it would revise

The NIH will offer the money as part of grant awards to nine institutions over a three year period. According to Dr Thomas Insel, director of the National

Medcon said its technology offers diagnostic digital image management and archiving, procedure reporting and workflow management. McKesson hopes the addition of these products will further strengthen its presence

Provid will employ its expertise in structure-based design, peptide mimetics technology, and medicinal chemistry to develop the lead compounds. “We are pleased to be complementing the biology of

Data from the clinical trials will then be used as part of Merck’s FDA application for Arcoxia. The FDA issued Arcoxia with an “approvable” in October last year,